Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-21-007332

Chief Commercial Officer sold 2,085 shares at an average $40.67 ($84,787)

From the SEC's structured data for this filing

Trades in this filing

VAN BEEK JEROEN B · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-18 Sale : show line 1 in the form −535 $39.83 $21,312 504,795 D
2021-02-18 Sale : show line 2 in the form −800 $40.44 $32,349 503,995 D
2021-02-18 Sale : show line 3 in the form −750 $41.50 $31,126 503,245 D
Open-market sales · 2,085 sh · avg $40.67 · $84,787
Loading xslF345X03/doc4.xml…